Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma
Multiple myeloma (MM) accounts for 1 % of all cancers and about 10 % of all hemoblastoses. The use of innovative technologies with the inclusion of targeted drugs leads to a significant improvement in the quality of pharmacotherapy and the achievement of overall survival (OS).The aim of the work is...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Izdatelstvo OKI,
2023-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|